IL6 and hepatocellular carcinoma: There was a decrease in the number of Treg/CD4(+) and Treg/CD3(+) along with an increase in the cytotoxicity of the CIK cells against HCC in vitro, suggesting the potential use of IL-6 in improving cancer immunotherapy [114].